{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:08:40Z","timestamp":1740146920329,"version":"3.37.3"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001502","name":"Blue Cross Blue Shield of Michigan Foundation","doi-asserted-by":"publisher","award":["002648.MG"],"award-info":[{"award-number":["002648.MG"]}],"id":[{"id":"10.13039\/100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Evidence for community-based strategies to reduce inpatient detoxification readmission for opioid use disorder (OUD) is scant. A pilot program was designed to provide individualized structured treatment plans, including addressing prolonged withdrawal symptoms, family\/systems assessment, and contingency management, to reduce readmission after the index inpatient detoxification.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A non-randomized quasi-experimental design was used to compare the pilot facilities (treatment) and comparison facilities before and after the program started, i.e., a simple difference-in-differences (DID) strategy. Adults 18 years and older who met the Diagnostic and Statistical Manual of Mental Disorders version 5 criteria for OUD and had an inpatient detoxification admission at any OUD treatment facility in two study periods between 7\/2016 and 3\/2020 were included. Readmission for inpatient detoxification in 90-days after the index stay was the primary outcome, and partial hospitalization, intensive outpatient care, outpatient services, and medications for OUD were the secondary outcomes. Six statistical estimation methods were used to triangulate evidence and adjust for potential confounding factors between treatment and comparison groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 2,320 unique patients in the pilot and comparison facilities with 2,443 index inpatient detoxification admissions in the pre- and post-periods were included. Compared with patients in comparison facilities, patients in the C.L.I.M.B. facilities had higher readmission in the pre-period (unadjusted readmission 17.0% vs. 10.6%), but similar rates in the post-period (12.3% vs. 10.6%) after the implementation of the pilot program. For 90-day readmission, all DID estimates were not statistically significant (adjusted estimates ranged from 6 to 9 percentage points difference favoring the C.L.I.M.B. program). There was no significant improvement in the secondary outcomes of utilizations in lower level of care and medications for OUD in C.L.I.M.B. facilities.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We found a reduction in readmission in the pilot facilities between the two periods, but the results were not statistically significant compared with the comparison facilities and the utilization of lower level of care services remained low. Even though providers in the pilot OUD treatment facilities actively worked with health plans to standardize care for patients with OUD, more strategies are needed to improve treatment engagement and retention after an inpatient detoxification.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0278208","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T18:54:17Z","timestamp":1671130457000},"page":"e0278208","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevention of 90-day inpatient detoxification readmission for opioid use disorder by a community-based life-changing individualized medically assisted evidence-based treatment (C.L.I.M.B.) program: A quasi-experimental study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9193-3380","authenticated-orcid":true,"given":"Zhehui","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canopy","family":"Roychoudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Pompos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"DiMaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Robinette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purva H.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0437-9276","authenticated-orcid":true,"given":"Rohon","family":"Roychoudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Beecroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"pone.0278208.ref001","first-page":"70","article-title":"Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths\u2014United States, 2013\u20132019.","author":"CL Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"pone.0278208.ref002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2019.05.003","article-title":"Opioid-related US hospital discharges by type, 1993\u20132016","volume":"103","author":"C Peterson","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"pone.0278208.ref003","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jama.2015.10345","article-title":"Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004\u20132013","volume":"314","author":"B Saloner","year":"2015","journal-title":"JAMA"},{"key":"pone.0278208.ref004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsat.2020.01.017","article-title":"Opioid overdose and inpatient care for substance use disorder care in Massachusetts","volume":"112","author":"JR Morgan","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"pone.0278208.ref005","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1186\/s12889-018-5982-8","article-title":"National trends and characteristics of inpatient detoxification for drug use disorders in the United States","volume":"18","author":"H Zhu","year":"2018","journal-title":"BMC Public Health"},{"key":"pone.0278208.ref006","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"JM Liebschutz","year":"2014","journal-title":"JAMA Intern Med"},{"key":"pone.0278208.ref007","doi-asserted-by":"crossref","first-page":"899","DOI":"10.7326\/M20-5475","article-title":"Preventing hospital readmission for patients with comorbid substance use disorder: A randomized trial","volume":"174","author":"J Gryczynski","year":"2021","journal-title":"Annals of Internal Medicine"},{"key":"pone.0278208.ref008","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1515\/jom-2021-0163","article-title":"Review of medication-assisted treatment for opioid use disorder","volume":"122","author":"N Ghanem","year":"2022","journal-title":"J Osteopath Med"},{"key":"pone.0278208.ref009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13722-022-00318-1","article-title":"Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.","volume":"17","author":"DM Hartung","year":"2022","journal-title":"Addiction Science & Clinical Practice"},{"key":"pone.0278208.ref010","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/jhm.12893","article-title":"Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine","volume":"17","author":"SL Calcaterra","year":"2022","journal-title":"Journal of Hospital Medicine"},{"key":"pone.0278208.ref011","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/add.14964","article-title":"Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis","volume":"115","author":"AY Walley","year":"2020","journal-title":"Addiction"},{"key":"pone.0278208.ref012","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","article-title":"Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study","volume":"326","author":"J Strang","year":"2003","journal-title":"BMJ"},{"key":"pone.0278208.ref013","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1177\/0033354918793627","article-title":"A Public Health Strategy for the Opioid Crisis","volume":"133","author":"B Saloner","year":"2018","journal-title":"Public Health Rep"},{"key":"pone.0278208.ref014","doi-asserted-by":"crossref","first-page":"e2023677","DOI":"10.1001\/jamanetworkopen.2020.23677","article-title":"Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US","volume":"3","author":"J Ballreich","year":"2020","journal-title":"JAMA Netw Open"},{"key":"pone.0278208.ref015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ADM.0b013e318166af74","article-title":"The Case for Chronic Disease Management for Addiction","volume":"2","author":"R Saitz","year":"2008","journal-title":"J Addict Med."},{"key":"pone.0278208.ref016","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jama.2013.277609","article-title":"Chronic Care Management for Dependence on Alcohol and Other Drugs: The AHEAD Randomized Trial","volume":"310","author":"R Saitz","year":"2013","journal-title":"JAMA"},{"key":"pone.0278208.ref017","volume-title":"Treating Addiction Like a Chronic Illness: A Practical Clinical Model. 6th ed. The American Psychiatric Association Publishing Textbook Of Substance Use Disorder Treatment.","author":"JL McCauley","year":"2021","edition":"6"},{"key":"pone.0278208.ref018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13722-019-0139-3","article-title":"Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence","volume":"14","author":"ME Godersky","year":"2019","journal-title":"Addict Sci Clin Pract"},{"key":"pone.0278208.ref019","article-title":"Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System","author":"BK Madras","year":"2020","journal-title":"NAM Perspectives"},{"key":"pone.0278208.ref020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2018.06.004","article-title":"Risks of fatal opioid overdose during the first year following nonfatal overdose","volume":"190","author":"M Olfson","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"pone.0278208.ref021","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-economics-080217-053402","article-title":"Econometric Methods for Program Evaluation","volume":"10","author":"A Abadie","year":"2018","journal-title":"Annu Rev Econ."},{"key":"pone.0278208.ref022","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10742-014-0123-z","article-title":"Using propensity scores in difference-in-differences models to estimate the effects of a policy change","volume":"14","author":"EA Stuart","year":"2014","journal-title":"Health Serv Outcomes Res Methodol"},{"volume-title":"The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","year":"2015","author":"American Society of Addiction Medicine","key":"pone.0278208.ref023"},{"key":"pone.0278208.ref024","first-page":"91","volume-title":"The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update","author":"American Society of Addiction Medicine","year":"2020"},{"key":"pone.0278208.ref025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1207\/S15327965PLI1104_01","article-title":"The \u201cWhat\u201d and \u201cWhy\u201d of Goal Pursuits: Human Needs and the Self-Determination of Behavior","volume":"11","author":"EL Deci","year":"2000","journal-title":"Psychological Inquiry"},{"key":"pone.0278208.ref026","doi-asserted-by":"crossref","first-page":"25310","DOI":"10.17226\/25310","article-title":"Committee on Medication-Assisted Treatment for Opioid Use Disorder, Board on Health Sciences Policy, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine","volume-title":"Medications for Opioid Use Disorder Save Lives.","author":"AI Leshner","year":"2019"},{"key":"pone.0278208.ref027","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s13063-016-1726-1","article-title":"The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.","volume":"17","author":"DH Gustafson","year":"2016","journal-title":"Trials"},{"journal-title":"Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses","year":"2021","author":"Agency for Healthcare Research and Quality","key":"pone.0278208.ref028"},{"key":"pone.0278208.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.05.031","article-title":"Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990\u20132014: A systematic review and meta-analysis","volume":"154","author":"HMX Lai","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"pone.0278208.ref030","doi-asserted-by":"crossref","first-page":"e2625","DOI":"10.1002\/hup.2625","article-title":"Multiple DSM-5 substance use disorders: A national study of US adults","volume":"32","author":"SE McCabe","year":"2017","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"pone.0278208.ref031","doi-asserted-by":"crossref","first-page":"107612","DOI":"10.1016\/j.drugalcdep.2019.107612","article-title":"Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder","volume":"205","author":"HS Connery","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"pone.0278208.ref032","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3390\/jcm11061594","article-title":"Prevalence of Opioid Use Disorder among Patients with Cancer-Related Pain: A Systematic Review","volume":"11","author":"C Preux","year":"2022","journal-title":"J Clin Med"},{"key":"pone.0278208.ref033","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2049463712438299","article-title":"Opioids and endocrine dysfunction","volume":"6","author":"O Seyfried","year":"2012","journal-title":"Br J Pain"},{"key":"pone.0278208.ref034","first-page":"4","article-title":"Assessment of Annual Cost of Substance Use Disorder in US Hospitals","author":"C Peterson","year":"2021","journal-title":"JAMA Network Open"},{"key":"pone.0278208.ref035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jpeds.2019.12.058","article-title":"Impact of Office-based Opioid Treatment on Emergency Visits and Hospitalization in Adolescents with Opioid Use Disorder","volume":"219","author":"KS Walker","year":"2020","journal-title":"J Pediatr"},{"journal-title":"HUD USPS ZIP Code Crosswalk Files","year":"2021","author":"U.S. Department of Housing and Urban Development","key":"pone.0278208.ref036"},{"key":"pone.0278208.ref037","first-page":"277","article-title":"Understanding and Enhancing the U.S. Department of Housing and Urban Development\u2019s ZIP Code Crosswalk Files","volume":"20","author":"R Wilson","year":"2018","journal-title":"Cityscape"},{"key":"pone.0278208.ref038","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making Neighborhood-Disadvantage Metrics Accessible\u2014The Neighborhood Atlas","volume":"378","author":"AJH Kind","year":"2018","journal-title":"N Engl J Med"},{"journal-title":"Area Deprivation Index v2018 Neighborhood Atlas","year":"2021","author":"University of Wisconsin School of Medicine and Public Health","key":"pone.0278208.ref039"},{"volume-title":"Child Opportunity Index. Institute for Child, Youth and Family Policy, Heller School for Social Policy and Management","year":"2021","key":"pone.0278208.ref040"},{"journal-title":"Social Vulnerability Index, Agency for Toxic Substances and Disease Registry Geospatial Research","year":"2021","author":"Centers for Disease Control and Prevention","key":"pone.0278208.ref041"},{"key":"pone.0278208.ref042","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies","volume":"46","author":"PC Austin","year":"2011","journal-title":"Multivariate Behav Res."},{"key":"pone.0278208.ref043","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/biomet\/asq035","article-title":"Bounded, efficient and doubly robust estimation with inverse weighting","volume":"97","author":"Z Tan","year":"2010","journal-title":"Biometrika"},{"key":"pone.0278208.ref044","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1111\/ectj.12097","article-title":"Double\/debiased machine learning for treatment and structural parameters","volume":"21","author":"V Chernozhukov","year":"2018","journal-title":"Econom J"},{"key":"pone.0278208.ref045","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/1468-0262.00442","article-title":"Efficient Estimation of Average Treatment Effects Using the Estimated Propensity Score","volume":"71","author":"K Hirano","year":"2003","journal-title":"Econometrica"},{"key":"pone.0278208.ref046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1198\/jbes.2009.07333","article-title":"Bias-Corrected Matching Estimators for Average Treatment Effects.","volume":"29","author":"A Abadie","year":"2011","journal-title":"Journal of Business & Economic Statistics"},{"volume-title":"Stata Statistical Software: Release 17.","year":"2017","author":"StataCorp","key":"pone.0278208.ref047"},{"volume-title":"Principles of Addiction Medicine:","year":"2003","author":"AW Graham","key":"pone.0278208.ref048"},{"key":"pone.0278208.ref049","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jsat.2012.08.019","article-title":"Buprenorphine from detox and beyond: preliminary evaluation of a pilot program to increase heroin dependent individuals\u2019 engagement in a full continuum of care","volume":"44","author":"DM Donovan","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"pone.0278208.ref050","doi-asserted-by":"crossref","first-page":"e2029676","DOI":"10.1001\/jamanetworkopen.2020.29676","article-title":"Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting","volume":"3","author":"JR Morgan","year":"2020","journal-title":"JAMA Network Open"},{"key":"pone.0278208.ref051","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2017.12.043","article-title":"Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service","volume":"186","author":"CD Nordeck","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"pone.0278208.ref052","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","article-title":"Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities","volume":"38","author":"R Mojtabai","year":"2019","journal-title":"Health Affairs"},{"key":"pone.0278208.ref053","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2020.8969","article-title":"Therapies Offered at Residential Addiction Treatment Programs in the United States","volume":"324","author":"T Beetham","year":"2020","journal-title":"JAMA"},{"key":"pone.0278208.ref054","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s40429-020-00344-6","article-title":"Review of Popularity and Quality Standards of Opioid-Related Smartphone Apps","volume":"7","author":"R Vilardaga","year":"2020","journal-title":"Curr Addict Rep."},{"key":"pone.0278208.ref055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/sim.2980","article-title":"Sample size and optimal design for logistic regression with binary interaction","volume":"27","author":"E. Demidenko","year":"2008","journal-title":"Stat Med."},{"key":"pone.0278208.ref056","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"JD Lee","year":"2018","journal-title":"Lancet"},{"key":"pone.0278208.ref057","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact","volume":"11","author":"JR Brooklyn","year":"2017","journal-title":"Journal of Addiction Medicine"},{"key":"pone.0278208.ref058","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention","volume":"32","author":"G D\u2019Onofrio","year":"2017","journal-title":"J Gen Intern Med"},{"key":"pone.0278208.ref059","doi-asserted-by":"crossref","first-page":"108335","DOI":"10.1016\/j.drugalcdep.2020.108335","article-title":"The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices","volume":"217","author":"SL Walsh","year":"2020","journal-title":"Drug and Alcohol Dependence"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T18:55:01Z","timestamp":1671130501000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0278208"}},"subtitle":[],"editor":[{"given":"Rikinkumar S.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0278208","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,12,15]]}}}